Primary immunodeficiency diseases are a group of more than 430 genetic conditions in which part of the immune system is missing or doesn’t work properly. Unlike immune problems caused by medications, infections like HIV, or malnutrition, these deficiencies are inherited. They’re present from birth, though symptoms can appear at any age. An estimated 1 in 10,000 people worldwide is affected, and the true number is likely higher because 70 to 90 percent of cases remain undiagnosed.
How Genetic Defects Weaken the Immune System
Your immune system has several lines of defense: white blood cells that hunt and kill invaders, antibody-producing cells that tag germs for destruction, and a set of proteins called the complement system that punches holes in bacteria. A primary immunodeficiency happens when a gene mutation disrupts one or more of these components. The specific gene that’s broken determines which part of the immune system fails and how severe the consequences are.
In some conditions, the problem is antibodies. Common variable immunodeficiency (CVID), one of the most frequently diagnosed forms, results in abnormally low levels of the protective antibodies your body needs to fight bacterial infections. In selective IgA deficiency, a glitch in how immune cells switch between antibody types leaves people short on one specific class of antibody. In hyper-IgM syndrome, a faulty gene prevents immune cells from cooperating properly, so the body gets stuck producing only one type of antibody and can’t generate the others.
Other conditions target the cells themselves. In severe combined immunodeficiency (SCID), sometimes called “bubble boy disease,” early immune cells fail to develop into the two main types of infection-fighting white blood cells. Babies born with SCID have essentially no functional immune system. In chronic granulomatous disease, white blood cells can swallow bacteria but can’t produce the chemical burst needed to actually kill them, leading to recurring abscesses in the lungs, liver, and skin. In Wiskott-Aldrich syndrome, a defective protein involved in cell structure causes problems with both immune function and blood clotting.
How These Conditions Are Inherited
Primary immunodeficiencies follow three main inheritance patterns. In autosomal dominant conditions, inheriting one abnormal copy of a gene from either parent is enough to cause disease, giving each child of an affected parent a 50 percent chance of being affected. In autosomal recessive conditions, a child needs two abnormal copies, one from each parent. When both parents are carriers, each child has a 25 percent chance of developing the disease. Parents in this case are typically healthy because their one working gene copy is enough.
Many of the most well-known immunodeficiencies, including a common form of SCID and a form where boys can’t produce mature antibody-making cells, follow an X-linked recessive pattern. Because boys have only one X chromosome, a single defective gene copy causes disease. Girls, with two X chromosomes, are usually protected because their second copy compensates. This is why several primary immunodeficiencies are far more common in boys.
Warning Signs to Recognize
The hallmark of primary immunodeficiency is infections that are unusually frequent, severe, or caused by organisms that rarely trouble healthy people. Clinical warning signs that prompt further investigation include:
- Recurrent ear infections (otitis media)
- Chronic or recurring sinus infections
- Pneumonia, especially more than once
- Unusual infections or unusual presentations in someone who is HIV-negative
- Chronic diarrhea or colitis
- Persistent skin infections or dermatitis
- Recurrent staph infections
- Persistent yeast or fungal infections
- Abscesses of the liver, lungs, or skin
- Infections of the central nervous system
No single infection proves an immunodeficiency exists. The pattern matters: infections that keep coming back despite appropriate treatment, that don’t respond well to antibiotics, or that break through despite vaccination are the strongest clues. A family history of similar problems adds weight.
How Primary Immunodeficiency Is Diagnosed
Testing usually starts with basic blood work to count different types of immune cells and measure antibody levels. If those results look abnormal, more targeted tests follow. For suspected antibody deficiencies, doctors measure how well your body responds to vaccines. You’d receive a standard immunization (such as a pneumonia vaccine) and then have blood drawn a few weeks later to see if your immune system produced the expected antibodies. A poor response is a strong indicator.
For CVID specifically, diagnosis requires an IgG antibody level below 5 grams per liter in adults, evidence that the immune system fails in practice (recurrent infections, lung damage, or autoimmune complications), no other explanation for the low levels, and age over four years. People with mildly low antibody levels who don’t meet these criteria are classified as having low antibodies of uncertain significance and monitored over time.
A technique called flow cytometry is used across nearly all types of immunodeficiency testing. It works by labeling immune cells with fluorescent markers and then counting and sorting them by type. This can reveal whether specific cell populations, like certain T cells or natural killer cells, are missing or abnormally low. For conditions affecting the ability of white blood cells to kill bacteria, a specialized test measures whether cells produce the expected chemical burst when activated.
For the most severe form, SCID, newborn screening has transformed diagnosis. A blood test developed in 2005 detects tiny DNA circles called TRECs that are produced when T cells mature. Babies with SCID have very low or undetectable levels. By 2018, all 50 U.S. states had adopted this screening. The result has been dramatic: most infants with SCID are now identified before they ever develop a serious infection, rather than being diagnosed only after becoming critically ill.
Treatment: Replacing What’s Missing
Treatment depends entirely on which part of the immune system is affected. For antibody deficiencies, the cornerstone is immunoglobulin replacement therapy, which delivers concentrated antibodies collected from thousands of blood donors. This can be given intravenously every three to four weeks or injected under the skin on a more frequent schedule, anywhere from daily to every two weeks. The subcutaneous option allows many people to treat themselves at home. The goal is to maintain antibody levels high enough to prevent infections, and most people stay on this therapy for life.
For SCID, the definitive treatment is a bone marrow or stem cell transplant, which rebuilds the immune system from scratch. Data shows that outcomes are dramatically better when transplant happens within the first three and a half months of life, before serious infections take hold. This is the core reason newborn screening matters so much: early detection directly improves survival.
Gene therapy is emerging as an option for specific conditions. In 2025, the FDA approved the first gene therapy for Wiskott-Aldrich syndrome. The treatment takes a patient’s own stem cells, corrects the defective gene in a lab, and infuses the repaired cells back. It’s currently approved for patients six months and older who need a transplant but don’t have a matched family donor available.
Living With Primary Immunodeficiency
Many people with milder forms, particularly selective IgA deficiency and some cases of CVID, lead relatively normal lives with appropriate management. The key is preventing infections from causing cumulative organ damage, particularly to the lungs. Chronic or repeated lung infections can lead to bronchiectasis, a permanent widening and scarring of the airways that progressively worsens breathing. This is one of the most common long-term complications and a major reason early diagnosis and consistent treatment matter.
Autoimmune problems are surprisingly common in people with primary immunodeficiency. A malfunctioning immune system doesn’t just underperform against infections; it can also misfire against the body’s own tissues, causing problems like low blood cell counts, joint inflammation, or gut disease. This overlap often delays diagnosis because doctors may initially focus on the autoimmune symptoms without recognizing the underlying immune defect.
With more than 430 distinct conditions now identified and genetic testing becoming more accessible, diagnoses that once took years of unexplained infections are increasingly caught earlier. For the 70 to 90 percent of people estimated to still be undiagnosed worldwide, the biggest barrier isn’t the availability of treatment. It’s recognizing that the pattern of infections they’ve been living with has a name and a cause.